We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.22%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$920B
AUM Growth
+$99.4B
Cap. Flow
+$40.5B
Cap. Flow %
4.41%
Top 10 Hldgs %
19.57%
Holding
7,602
New
674
Increased
3,069
Reduced
2,328
Closed
737

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Healthcare 10.48%
3 Financials 8.96%
4 Consumer Discretionary 8.42%
5 Industrials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAPO
6551
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$14 ﹤0.01%
4
AKA icon
6552
a.k.a. Brands
AKA
$119M
$13 ﹤0.01%
3
-711
-100% -$3.47K
AQB icon
6553
AquaBounty Technologies
AQB
$4.73M
$13 ﹤0.01%
2
CLNN icon
6554
Clene
CLNN
$60.3M
$13 ﹤0.01%
1
EQAL icon
6555
Invesco Russell 1000 Equal Weight ETF
EQAL
$816M
0
RFL icon
6556
Rafael Holdings
RFL
$103M
$13 ﹤0.01%
6
XCUR icon
6557
Exicure
XCUR
$11M
$13 ﹤0.01%
2
ACOR
6558
DELISTED
Acorda Therapeutics
ACOR
$13 ﹤0.01%
1
HOOK
6559
DELISTED
HOOKIPA Pharma
HOOK
$12 ﹤0.01%
1
RSSS icon
6560
Research Solutions
RSSS
$74.9M
$12 ﹤0.01%
6
VNCE icon
6561
Vince Holding Corp
VNCE
$79.9M
$12 ﹤0.01%
4
PHIO icon
6562
Phio Pharmaceuticals
PHIO
$11.4M
0
NMRD
6563
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$11 ﹤0.01%
12
HGEN
6564
DELISTED
HUMANIGEN, INC.
HGEN
$11 ﹤0.01%
69
NBTX
6565
Nanobiotix
NBTX
$1.92B
$10 ﹤0.01%
+2
New +$9
MTBL
6566
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$10 ﹤0.01%
6
APGB
6567
DELISTED
Apollo Strategic Growth Capital II
APGB
$10 ﹤0.01%
1
-50,002
-100% -$512K
PNBK icon
6568
Patriot National Bancorp
PNBK
$123M
$9 ﹤0.01%
+1
New +$8
VMO icon
6569
Invesco Municipal Opportunity Trust
VMO
$651M
$9 ﹤0.01%
1
-34,189
-100% -$323K
FUSN
6570
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$9 ﹤0.01%
2
ONCT
6571
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$9 ﹤0.01%
1
SNDL icon
6572
Sundial Growers
SNDL
$312M
$8 ﹤0.01%
6
-30,665
-100% -$46.5K
SYBX
6573
DELISTED
Synlogic
SYBX
$8 ﹤0.01%
1
-28
-97% -$234
BIMI
6574
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$8 ﹤0.01%
+6
New +$6
FCG icon
6575
First Trust Natural Gas ETF
FCG
$632M
-49,476
Closed -$1.12M

Similar funds

JP Morgan Chase's Q2 2023 Portfolio in Review

As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.

  • JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
  • JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
  • JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
  • JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
  • JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
  • JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.